Key Clinical Message
The authors urge clinicians to observe the early signs of lower
gastrointestinal bleeding and perforation associated with tocilizumab
treatment in patients with COVID-19. On-time recognition and performance
of exploratory laparotomy with double-barrel colostomy are effective
life-saving measures.